Insider Trading July 13, 2026 10:33 AM

ConnectM CFO Mahesh Choudhury Accumulates $31,766 in Shares Amid Stock Decline

Principal Financial Officer Buys 3,622 Shares Over Five Trading Days as CNTM Stock Falls Below Purchase Prices

By Marcus Reed
Share
Twitter Reddit Facebook LinkedIn
CNTM

Mahesh Choudhury, Principal Financial Officer of ConnectM Technology Solutions, Inc. (NASDAQ:CNTM), has acquired 3,622 shares of the company's common stock over a five-day period. The purchases, totaling approximately $31,766, occurred between June 22, 2026, and June 26, 2026. Choudhury's transactions took place while the stock was declining, with shares currently trading at $6.70, significantly below the purchase prices of $8.49 to $9.06 per share. Following these acquisitions, Choudhury directly holds 40,814 shares of ConnectM Technology Solutions common stock. The insider buying occurs against a challenging backdrop for the $41 million market cap company, which has seen shares fall 41% over six months. However, InvestingPro analysis suggests the stock is undervalued at current levels, appearing on the platform's most undervalued stocks list.

ConnectM CFO Mahesh Choudhury Accumulates $31,766 in Shares Amid Stock Decline
CNTM
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Mahesh Choudhury, Principal Financial Officer of ConnectM Technology Solutions, Inc. (NASDAQ:CNTM), acquired 3,622 shares of the company's common stock over five trading days, totaling approximately $31,766.
  • The purchases were made between June 22, 2026, and June 26, 2026, at prices ranging from $8.49 to $9.06 per share, while the stock was declining 12% over the past week.
  • Following these acquisitions, Choudhury directly holds 40,814 shares of ConnectM Technology Solutions common stock, and the stock is currently trading at $6.70, well below his purchase prices.

Mahesh Choudhury, Principal Financial Officer of ConnectM Technology Solutions, Inc. (NASDAQ:CNTM), has recently executed a series of purchases involving the company's common stock. Over a span of five trading days, Choudhury acquired a total of 3,622 shares, with the aggregate value of these transactions reaching approximately $31,766.

The acquisitions were executed between June 22, 2026, and June 26, 2026. The shares were bought through Mr. Choudhury's brokerage account at prices ranging from $8.49 to $9.06 per share. These purchases occurred while the stock was experiencing a decline, having fallen 12% over the past week. At the time of reporting, shares were trading at $6.70, which is notably below the prices at which Choudhury acquired the shares.

Following these recent acquisitions, Mr. Choudhury's direct holdings in ConnectM Technology Solutions common stock stand at 40,814 shares. In addition to his role as Principal Financial Officer, Mr. Choudhury also serves as Vice President of US Operations and Secretary for the company.

The insider buying takes place against a challenging backdrop for the $41 million market cap company. Over the past six months, the stock has declined by 41%. Despite this downward trend, InvestingPro analysis suggests that the stock is undervalued at current levels. The company's stock appears on the platform's list of most undervalued stocks. Subscribers to the platform can access comprehensive Fair Value analysis and 10 additional ProTips for CNTM.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.ConnectM Tech SolutionsFollowAnalyze CNTMIncluded in our AI-picked strategies·Review strategies6.70▼-0.63(-8.54%)Real-time Data·10:05:31·USD1D1W1M6M1Y5YMaxCreated with Highcharts 11.4.813:5513:5613:5713:5813:5914:0014:0114:0214:0314:046.56.7577.25Analyze CNTMIs your CNTM trade worth the risk?Before you click

Risks

  • The stock has declined 41% over the past six months, indicating a challenging backdrop for the $41 million market cap company.
  • The current stock price of $6.70 is significantly below the purchase prices of $8.49 to $9.06 per share, suggesting potential downside risk for the stock.
  • The stock appears on InvestingPro's list of most undervalued stocks, but this analysis may not reflect the true value of the company.

More from Insider Trading

Saba Capital Reduces Position in BlackRock ESG Capital Allocation Term Trust with $2.08 Million Sale Jul 13, 2026 Insider Activity: Coastlands Capital Expands Position in ADIAL PHARMACEUTICALS Amid Financial Restructuring Jul 13, 2026 Anixa Biosciences CEO Purchases $15,200 in Shares Amid Clinical Milestones Jul 13, 2026 Iperionx CEO Arima Acquires $497,227 in Company Shares Amid Strategic Positioning Jul 13, 2026 IperionX Leadership Increases Stake Amid Market Volatility Jul 13, 2026